This report explores the integration of GLP-1 medications into oncology nursing, highlighting their impact on patient care.
New drugs and treatments, mechanisms, and toxicity profiles require rapid integration into already complex care environments. Simultaneously, novel findings require vigilance within evidence-based practice. This combination is one of the more challenging aspects of oncology nursing. Because of the holistic nature of cancer care, oncology nurses increasingly manage non-oncologic medications that intersect with cancer care.
No takes yet. Share an insight, caveat, or question.
Joni L Watson (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: